A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta ...
Cell & Microbiology
Sep 23, 2021
0
546
The researchers' original task was to figure out how certain polymer nanomaterials provided for a low-inflammatory immune response and yet were able to boost antibody production as part of a single dose of vaccine.
Bio & Medicine
Sep 22, 2021
0
62
At least 18 of the 20 gorillas at Atlanta's zoo have now tested positive for COVID-19, an outbreak that began just days before the zoo had hoped to obtain a veterinary vaccine for the primates, officials said Tuesday.
Veterinary medicine
Sep 15, 2021
0
44
Many people suffering from diseases like Crohn's disease, rheumatoid arthritis, and diabetes inject themselves or have to receive drug infusions to help treat their disease. These injections require training, equipment and ...
Biotechnology
Aug 30, 2021
0
123
A multi-institutional team led by researchers at Vanderbilt University Medical Center has isolated monoclonal antibodies that in laboratory and animal studies prevented infection by alphaviruses, including the often-lethal ...
Cell & Microbiology
Aug 20, 2021
0
260
As the SARS-CoV-2 virus that causes COVID-19 continues to evolve, immunologists and infectious diseases experts are eager to know whether new variants are resistant to the human antibodies that recognized initial versions ...
Cell & Microbiology
Jul 23, 2021
1
595
Scientists have developed a "nanobody"—a small fragment of a llama antibody—that is capable of chasing out human cytomegalovirus (HCMV) as it hides away from the immune system. This then enables immune cells to seek out ...
Bio & Medicine
Jul 22, 2021
0
48
For the first time in the UAE, researchers at NYU Abu Dhabi have used nuclear magnetic resonance techniques to determine the structure of a specific nanobody, Nb23, potentially leading to a better understanding of how this ...
Biochemistry
Jul 2, 2021
0
9
When harmful bacteria or viruses enter the body, immune cells spot telltale proteins known as antigens on the invaders' surfaces and send out armies of antibodies to fend them off. If some of those antibodies have just the ...
Biochemistry
Jun 28, 2021
0
34
Scientists from within the Antibody and Vaccine Group at the University of Southampton have gained novel insights into how an important class of immune receptors called tumor necrosis factor receptors (TNFR) are activated.
Molecular & Computational biology
Jun 25, 2021
0
15
